PROFERDEX Drug Patent Profile
Which patents cover Proferdex, and when can generic versions of Proferdex launch?
Proferdex is a drug marketed by New River and is included in one NDA.
The generic ingredient in PROFERDEX is iron dextran. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the iron dextran profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROFERDEX?
- What are the global sales for PROFERDEX?
- What is Average Wholesale Price for PROFERDEX?
Summary for PROFERDEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 22 |
| Patent Applications: | 1,984 |
| DailyMed Link: | PROFERDEX at DailyMed |
US Patents and Regulatory Information for PROFERDEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| New River | PROFERDEX | iron dextran | INJECTABLE;INJECTION | 017807-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
